Cutter Capital Management »

Insmed shares owned by Cutter Capital Management

Quarter-by-quarter ownership of Insmed (INSM) shares owned by Cutter Capital Management from 13F filings

Historical chart of Cutter Capital Management investment in Insmed

Tip: Access up to 7 years of quarterly data

All positions including Insmed held by Cutter Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Insmed by Cutter Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $13M 414k 30.99

More positions owned by Cutter Capital Management

Amgen (AMGN)
Merck & Co (MRK)
Amicus Therapeutics (FOLD)
Insmed Com Par $.01 (INSM)
BioMarin Pharmaceutical (BMRN)
Roivant Sciences SHS (ROIV)
Exelixis (EXEL)
Teva Pharmaceutical Inds Sponsored Ads (TEVA)
Royalty Pharma Shs Class A (RPRX)
ACADIA Pharmaceuticals (ACAD)
BioCryst Pharmaceuticals (BCRX)
Halozyme Therapeutics (HALO)
Perrigo SHS (PRGO)
Pfizer (PFE)
Bristol Myers Squibb (BMY)

View all positions for Cutter Capital Management

Top funds holding Insmed

Vanguard Group
T. Rowe Price Associates
Palo Alto Investors
William Blair Investment Management
Franklin Resources
Bellevue Group
Alliancebernstein
Bank of New York Mellon
Holocene Advisors
Millennium Management
Balyasny Asset Management
Norges Bank Investment Management
Marshall Wace
Principal Financial Group
Henderson Group

View all funds holding Insmed